Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Biote (BTMD) Preferred Stock Liabilities (2021 - 2022)

Biote has reported Preferred Stock Liabilities over the past 2 years, most recently at $317.5 million for Q1 2022.

Quarterly results put Preferred Stock Liabilities at $317.5 million for Q1 2022, changed 0.0% from a year ago — trailing twelve months through Mar 2022 was $317.5 million (changed 0.0% YoY), and the annual figure for FY2021 was $317.5 million, changed.
Preferred Stock Liabilities for Q1 2022 was $317.5 million at Biote, roughly flat from $317.5 million in the prior quarter.
Over the last five years, Preferred Stock Liabilities for BTMD hit a ceiling of $317.5 million in Q2 2021 and a floor of $317.5 million in Q1 2021.